CBD of Denver Inc. (CBDD) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CBDD representa a CBD of Denver Inc., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 51/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026CBD of Denver Inc. (CBDD) Resumen de Asistencia Médica y Tuberías
CBD of Denver Inc. is a cannabidiol (CBD) product company involved in the research, development, and distribution of premium hemp extract products. Operating as a subsidiary of Swiss Industry Ventures AG, the company focuses on commercializing CBD products within the specialty and generic drug manufacturing sector.
Tesis de Inversión
CBD of Denver Inc. presents a speculative investment opportunity within the rapidly evolving CBD market. The company's focus on premium hemp extract products and its position as a subsidiary of Swiss Industry Ventures AG could provide a competitive edge. However, the company's financial performance and market capitalization of $0.00B indicate significant risks. A gross margin of 27.1% suggests potential profitability challenges. The negative beta of -10.69 indicates an inverse correlation with the market, which could be a double-edged sword. Growth catalysts include potential expansion into new product lines and geographic markets. Investors should carefully evaluate the company's OTC status and associated risks before considering an investment.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.00B reflects the company's small size and potential volatility.
- Gross Margin of 27.1% indicates the profitability of CBDD's core operations.
- Beta of -10.69 suggests an inverse correlation with the broader market.
- CBDD operates as a subsidiary of Swiss Industry Ventures AG.
- CBDD focuses on the development and commercialization of cannabidiol (CBD) products.
Fortalezas
- Focus on premium hemp extract products.
- Subsidiary of Swiss Industry Ventures AG.
- Established presence in the CBD market.
- Commitment to research and development.
Debilidades
- Small market capitalization.
- Limited financial resources.
- Dependence on the CBD market.
- OTC market listing.
Catalizadores
- Upcoming: Potential expansion into new therapeutic areas.
- Upcoming: Geographic expansion into new markets.
- Upcoming: Development of innovative CBD products.
- Ongoing: Strategic partnerships and acquisitions.
- Ongoing: Focus on quality and compliance.
Riesgos
- Potential: Intense competition in the CBD market.
- Potential: Evolving regulations and consumer preferences.
- Potential: Negative publicity or product recalls.
- Potential: Fluctuations in the price of hemp extract.
- Ongoing: Limited financial resources.
Oportunidades de crecimiento
- Expansion into New Therapeutic Areas: CBD of Denver Inc. has the opportunity to expand its product line into new therapeutic areas, such as pain management, anxiety relief, and sleep disorders. The market for CBD-based therapeutic products is growing rapidly, driven by increasing consumer awareness and scientific research. By developing and commercializing targeted CBD formulations, CBD of Denver Inc. can tap into this lucrative market segment and differentiate itself from competitors. This expansion could involve partnerships with healthcare providers and research institutions. The timeline for this growth opportunity is estimated at 2-3 years, with a potential market size of $5 billion.
- Geographic Expansion: CBD of Denver Inc. can pursue geographic expansion into new markets, both domestically and internationally. The global CBD market is highly fragmented, with significant growth potential in emerging markets. By establishing distribution partnerships and tailoring its product offerings to local preferences, CBD of Denver Inc. can expand its reach and increase its revenue. This expansion could involve entering into joint ventures or acquiring local CBD companies. The timeline for this growth opportunity is estimated at 3-5 years, with a potential market size of $10 billion.
- Development of Innovative CBD Products: CBD of Denver Inc. can invest in research and development to create innovative CBD products with enhanced efficacy and bioavailability. This could involve developing novel formulations, delivery systems, and extraction methods. By patenting its innovations and establishing a strong intellectual property portfolio, CBD of Denver Inc. can gain a competitive advantage and attract strategic partners. The timeline for this growth opportunity is estimated at 2-4 years, with a potential market size of $3 billion.
- Strategic Partnerships and Acquisitions: CBD of Denver Inc. can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This could involve partnering with established healthcare companies, retailers, or distributors. By acquiring complementary businesses, CBD of Denver Inc. can gain access to new technologies, products, and distribution channels. The timeline for this growth opportunity is estimated at 1-3 years, with a potential market size of $2 billion.
- Focus on Quality and Compliance: CBD of Denver Inc. can differentiate itself by focusing on product quality and regulatory compliance. This involves implementing rigorous quality control measures, obtaining certifications, and adhering to all applicable regulations. By building a reputation for quality and compliance, CBD of Denver Inc. can gain the trust of consumers and healthcare providers. The timeline for this growth opportunity is ongoing, with a potential market size of $1 billion.
Oportunidades
- Expansion into new therapeutic areas.
- Geographic expansion into new markets.
- Development of innovative CBD products.
- Strategic partnerships and acquisitions.
Amenazas
- Intense competition in the CBD market.
- Evolving regulations and consumer preferences.
- Potential for negative publicity or product recalls.
- Fluctuations in the price of hemp extract.
Ventajas competitivas
- Proprietary CBD formulations and extraction methods.
- Established distribution network.
- Strong brand reputation for quality and compliance.
- Strategic partnerships with key players in the healthcare and wellness industries.
Acerca de CBDD
CBD of Denver Inc., formerly known as Verde Media Group, Inc., was rebranded in 2018 to focus on the burgeoning cannabidiol (CBD) market. The company is dedicated to the research, development, and commercialization of a range of CBD products. Its core business revolves around the creation and distribution of premium hemp extract products, catering to a growing demand for CBD-based solutions. Headquartered in Centennial, Colorado, CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG, leveraging its parent company's resources and expertise. The company's evolution reflects the increasing acceptance and market potential of CBD in various applications, from wellness to potential therapeutic uses. CBD of Denver Inc. aims to establish itself as a key player in the CBD market by focusing on product quality, innovation, and strategic distribution partnerships. The company's commitment to research and development underscores its ambition to stay at the forefront of CBD advancements and capitalize on emerging opportunities within the healthcare and wellness sectors. CBD of Denver Inc. distributes its products through various channels, targeting both retail consumers and potential business-to-business partnerships.
Qué hacen
- Develops and commercializes cannabidiol (CBD) products.
- Engages in the research of hemp extract products.
- Distributes premium hemp extract products.
- Focuses on the wellness and potential therapeutic applications of CBD.
- Operates as a subsidiary of Swiss Industry Ventures AG.
- Aims to establish a strong presence in the CBD market.
Modelo de Negocio
- Develops and formulates CBD products.
- Manufactures or outsources the production of CBD products.
- Distributes CBD products through various channels, including retail and online sales.
- Generates revenue from the sale of CBD products.
Contexto de la Industria
CBD of Denver Inc. operates within the Drug Manufacturers - Specialty & Generic industry, which is experiencing significant growth due to the increasing acceptance and legalization of cannabis and CBD products. The market is characterized by intense competition, with numerous companies vying for market share. The industry is also subject to evolving regulations and consumer preferences. CBD of Denver Inc.'s success depends on its ability to differentiate its products, navigate the regulatory landscape, and establish strong distribution channels. The global CBD market is projected to reach billions of dollars in the coming years, presenting both opportunities and challenges for companies like CBD of Denver Inc.
Clientes Clave
- Consumers seeking wellness and therapeutic benefits from CBD.
- Retailers and distributors of CBD products.
- Healthcare providers interested in CBD-based solutions.
- Businesses seeking to incorporate CBD into their products.
Finanzas
Gráfico e información
Precio de la acción de CBD of Denver Inc. (CBDD): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CBDD.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CBDD.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CBDD.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CBDD en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Información del mercado OTC de CBDD
The OTC Other tier represents the lowest tier of the OTC market, indicating that CBD of Denver Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, which increases investment risk. Investing in companies on the OTC Other tier requires a high degree of due diligence and risk tolerance due to the potential for fraud, lack of liquidity, and limited information availability. These companies are not required to be SEC reporting.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure.
- Potential for fraud or manipulation.
- Lack of liquidity.
- High price volatility.
- Limited regulatory oversight.
- Verify the company's management team and their track record.
- Review the company's financial statements, if available.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor.
- Confirm the company's good standing with the Secretary of State.
- Company is a subsidiary of Swiss Industry Ventures AG.
- Company has been in operation since 2018.
- Company focuses on a growing market segment (CBD).
- Company has a defined business model.
- Company has a physical headquarters in Centennial, Colorado.
Acciones de CBD of Denver Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar CBDD?
CBD of Denver Inc. (CBDD) actualmente tiene una puntuación IA de 51/100, indicando puntuación moderada. Fortaleza clave: Focus on premium hemp extract products.. Riesgo principal a monitorear: Potential: Intense competition in the CBD market.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CBDD?
CBDD actualmente puntúa 51/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CBDD?
Los precios de CBDD se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CBDD?
La cobertura de analistas para CBDD incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CBDD?
Las categorías de riesgo para CBDD incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition in the CBD market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CBDD?
La relación P/E para CBDD compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CBDD sobrevalorada o infravalorada?
Determinar si CBD of Denver Inc. (CBDD) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CBDD?
CBD of Denver Inc. (CBDD) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited due to the company's OTC listing and disclosure status.
- AI analysis is pending for CBDD.